Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating intravenous buprenorphine for acute postoperative pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Other Acute Postoperative Pain, Prolonged Endotracheal Intubation | Phase 3 | Status: WITHDRAWN